FDA
Artificial Intelligence
뉴럴링크, 안전성 논란에도 560억 추가 펀딩
일론 머스크의 뇌 임플란트 스타트업 뉴럴링크가 4300만달러(약 560억원)의 추가 투자를 받았다. 끊이지 않는 안전성 논란에도 총 투자액은 3억2300만달러(약 4200억원)에 달하게 됐다.
테크크런치는 26일(현지시간) 뉴럴링크가 최근 미국 증권거래위원회(SEC)에 4300만달러 추가 유치를 신고했다고 보도했다. 투자에는 피터 틸이...
Artificial Intelligence
WiseAI, patent registration for AI dementia diagnosis aid…Entering the healthcare market
Smart AI (CEO Song Hyeong-seok), a synthetic intelligence (AI) expert, announced on the eleventh that it has accomplished patent registration for AI dementia diagnosis assisting technology.
This patent is about 'a dementia patient management...
Artificial Intelligence
Neuralink Receives FDA Approval for Human Clinical Trials
Bloomberg reported on the twenty sixth (local time) that Neuralink, a brain-computer connection technology (BCI) company, has received approval from the US Food and Drug Administration (FDA) for human clinical trials.
In keeping with this,...
Artificial Intelligence
Here Come the Code Cops: Senate Hearing Opens Door to FDA for Algorithms & AI Occupational Licensing
The code cops are coming for artificial intelligence (AI) and proposing an enormous latest national and international information control system for digital technologies.The U.S. Senate Judiciary Committee held a hearing this morning on, “Oversight...
Recent posts
